Investor Presentation via Engage Investor
Roquefort Therapeutics PLC will host a live interactive presentation on the Engage Investor platform on September 29, 2025, at 4pm BST. The presentation aims to update investors on the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharma. The company encourages current shareholders and interested investors to join the presentation and pre-submit questions via the Engage Investor platform.
Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes
Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company, announces that the Company's Chairman Stephen West alongside Edward Painter and Sridhar Vempati, Chairman and Chief Strategy Officer respectively of A2A Pharmaceuticals, Inc. ("A2A Pharma") will host a live interactive presentation on the Engage Investor platform on Monday, 29 September 2025 at 4pm BST.
The objective of the presentation is to provide investors with an update relating to the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharma.
All current shareholders and interested investors are invited to join and investors are encouraged to pre-submit questions via the Engage Investor platform. Investors can also submit questions at any time during the live presentation.
Investors can sign up to Engage Investor at no cost and follow Roquefort Therapeutics from their personalised investor hub.
Register interest in this event here:
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.